PNM Resources, Inc. (NYSE:PNM) shares moved down -0.39% in last trading session and ended the day at $33.35. PNM Gross Margin is 50.60% and its has a return on assets of 0.30%. PNM Resources, Inc. (NYSE:PNM) quarterly performance is 13.35%.
PNM Resources, Inc. (NYSE:PNM) management will meet with analysts and investors next week in Milan, London and Zurich. Management is expected to affirm the company’s 2016 consolidated ongoing earnings guidance of $1.55 to $1.76per diluted share during the meetings. Presentation materials are available on the company’s website athttp://www.pnmresources.com/investors/events.cfm.
Continental Building Products, Inc. (NYSE:CBPX) ended the last trading day at $18.06. Company weekly volatility is calculated as 3.82% and price to cash ratio as 51.15. Continental Building Products, Inc. (NYSE:CBPX) showed a weekly performance of 5.49%.
Continental Building Products, Inc. (NYSE:CBPX) announced that Chantal D. Veevaete and Michael J. Keough will join its Board of Directors as independent directors, effective on March 14, 2016.
On 21 March, WPX Energy, Inc. (NYSE:WPX) shares advanced 2.58% and was closed at $6.37. WPX EPS growth in last 5 year was -7.90%. WPX Energy, Inc. (NYSE:WPX) year to date (YTD) performance is 10.98%.
WPX Energy, Inc. (NYSE:WPX) announced that it has amended and restated its revolving credit facility. WPX received total commitments of $1.2 billion on a senior secured facility, with an initial borrowing base of $1.025 billion. The revolver matures on October 29, 2019.
Novogen Limited (NASDAQ:NVGN) shares advanced 13.75% in last trading session and ended the day at $2.48. NVGN has a return on assets of -59.10%. Novogen Limited (NASDAQ:NVGN) quarterly performance is 5.97%.
Novogen Limited (NASDAQ:NVGN) announced that it has received a cash refund of $2.8M from the Australian Taxation Office under the R&D Tax Incentive Program for the financial year ending 30 June 2015. This will support the Company’s preparations to progress Cantrixil (TRXE-002-1), its lead superbenzopyran (SBP) drug candidate, to Phase 1 clinical trial in 2016.
Charles & Colvard Ltd. (NASDAQ:CTHR) caters to the Services space. It has a net profit margin of -31.20% and weekly performance is -1.57%. On the last day of trading company shares ended up at $1.25. Charles & Colvard Ltd. (NASDAQ:CTHR) distance from 50-day simple moving average (SMA50) is -0.90%.
Charles & Colvard Ltd. (NASDAQ:CTHR) said that, survive to it needs to change – and quickly.